Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Antibody-based immunotoxins for the treatment of cancer
Nurit Becker,
Itai Benhar
*
*
Corresponding author for this work
Biotechnology
Tel Aviv University
Research output
:
Contribution to journal
›
Article
›
peer-review
56
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antibody-based immunotoxins for the treatment of cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antibody-based
100%
Bacterial Origin
16%
Cancer Treatment
100%
Cell Death
16%
Chimeric Protein
16%
Clinical Evaluation
16%
Clinical Trials
16%
Effector Domain
16%
Effector Molecules
16%
Guided Missile
16%
Immunogenic
16%
Immunotoxin
100%
Monoclonal Antibody
16%
Plant Origin
16%
Protein Toxin
33%
Recombinant Antibody
16%
Research Progression
16%
Specific Targeting
16%
Target Specificity
16%
Targeted Cancer Therapeutics
16%
Targeting Moieties
50%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Protein
16%
Clinical Trial
33%
Immunotoxin
100%
Malignant Neoplasm
100%
Monoclonal Antibody
16%
Protein Toxins
33%
Recombinant Antibody
16%
Side Effect
16%